Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, et al.
Nature Immunology (2021) Vol. 22, Iss. 10, pp. 1306-1315
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 589
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 247
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 208
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 152
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Baoling Ying, Bradley Whitener, Laura A. VanBlargan, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 630
Open Access | Times Cited: 69
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates
Kizzmekia S. Corbett, Matthew Gagné, Danielle A. Wagner, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1343-1353
Open Access | Times Cited: 99
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
Michael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 85
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Kaichun Wu, Angela Choi, Matthew Koch, et al.
Vaccine (2021) Vol. 39, Iss. 51, pp. 7394-7400
Open Access | Times Cited: 83
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Matthew Gagné, Kizzmekia S. Corbett, Barbara J. Flynn, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 113-130.e15
Open Access | Times Cited: 73
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Kaichun Wu, Angela Choi, Matthew Koch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 54
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, et al.
Science Immunology (2022) Vol. 7, Iss. 72
Open Access | Times Cited: 37
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
Yuri Furusawa, Maki Kiso, Shun Iida, et al.
EBioMedicine (2023) Vol. 91, pp. 104561-104561
Open Access | Times Cited: 34
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
Madhu Prabhakaran, Flávio Lemos Matassoli, David J. Leggat, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 12
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
Neeltje van Doremalen, Jonathan E. Schulz, Danielle R. Adney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
Cyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.
Cell (2022) Vol. 185, Iss. 25, pp. 4811-4825.e17
Open Access | Times Cited: 31
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
Christine E Nelson, Sivaranjani Namasivayam, Taylor W. Foreman, et al.
Science Immunology (2022) Vol. 7, Iss. 70
Open Access | Times Cited: 30
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, et al.
Med (2021) Vol. 2, Iss. 12, pp. 1327-1341.e4
Open Access | Times Cited: 36
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Yoshihiro Kawaoka, Ryuta Uraki, Maki Kiso, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 26
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
I‐Ting Teng, Alexandra F. Nazzari, Misook Choe, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268767-e0268767
Open Access | Times Cited: 23
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
Petra Mooij, Juan García‐Arriaza, Patricia Pérez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 316-334
Closed Access | Times Cited: 13
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
I‐Ting Teng, Alexandra F. Nazzari, Misook Choe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top